Oppenheimer says Freshpet can keep sales growth steady, looks cheaper after the pullback, and could still appeal as a takeover target. Oppenheimer upgraded Freshpet to Outperform and set an $80 price ...

Futures in Japan, China, and Singapore fell as peak harvest season neared and holiday profit-taking kicked in, while oil and currency moves helped cap the drop. Rubber prices fell across Japan, China, ...

The oil giant plans a 2028 move to Timber Square to bring leadership and engineers together, while it tightens its focus on oil and gas and works down debt via asset sales. BP’s new base will be ...

What’s going on here? It doesn’t look like the global memory chip boom will be quieting down any time soon – at least not according to SK Group. Memory chips are the fast-access storage that ...

ANZ now expects December-quarter GDP growth of 0.2% — well under the RBNZ’s 0.5% view — as weak construction and food manufacturing offset gains from lower rates, farm incomes, and tourism. ANZ ...

The Taiwanese firm is the world’s biggest contract chipmaker, manufacturing advanced AI processors designed by the likes of Nvidia, AMD, and Broadcom. This week, TSMC said that its January and ...

Woodward's aerospace segment is set for impressive growth, with earnings per share predicted to rise substantially. Thanks to higher production volumes and savvy pricing, the company is optimizing ...

China's legal framework is under pressure as bankruptcy filings soar, affecting both domestic and global investors. Take Dalian Chuming Meat Processing's saga: its 2019 bankruptcy left US shareholders ...

The firm files for 27 new leveraged funds targeting tech and crypto, testing regulatory limits and raising concerns over market risk. Leveraged ETFs are designed to magnify both gains and losses by ...

Abu Dhabi's Mubadala challenges B3 with tech advances and cost cuts, eyeing major players like Petrobras and Banco do Brasil. The Base Exchange aims to disrupt Brazil's trading landscape by ...

What’s going on here? Mali’s military-led government approved a draft decree to extend Barrick’s permit for the Loulo–Gounkoto gold complex by 10 years, safeguarding the country’s biggest gold ...

What’s going on here? Alnylam Pharmaceuticals just posted a blockbuster quarter, with net product revenue soaring 103% to $1.24 billion – powered by surging demand for its transthyretin amyloidosis ...